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Abstract
Background: Shigella flexneri inhibits apoptosis in infected epithelial cells. In order to understand the pro-survival 
effects induced by the bacteria, we utilized apoptosis-specific microarrays to analyze the changes in eukaryotic gene 
expression in both infected and uninfected cells in the presence and absence of staurosporine, a chemical inducer of 
the intrinsic pathway of apoptosis. The goal of this research was to identify host factors that contribute to apoptosis 
inhibition in infected cells.
Results: The microarray analysis revealed distinct expression profiles in uninfected and infected cells, and these 
changes were altered in the presence of staurosporine. These profiles allowed us to make comparisons between the 
treatment groups. Compared to uninfected cells, Shigella-infected epithelial cells, both in the presence and absence of 
staurosporine, showed significant induced expression of JUN, several members of the inhibitor of apoptosis gene 
family, nuclear factor κB and related genes, genes involving tumor protein 53 and the retinoblastoma protein, and 
surprisingly, genes important for the inhibition of the extrinsic pathway of apoptosis. We confirmed the microarray 
results for a selection of genes using in situ hybridization analysis.
Conclusion: Infection of epithelial cells with S. flexneri induces a pro-survival state in the cell that results in apoptosis 
inhibition in the presence and absence of staurosporine. The bacteria may target these host factors directly while some 
induced genes may represent downstream effects due to the presence of the bacteria. Our results indicate that the 
bacteria block apoptosis at multiple checkpoints along both pathways so that even if a cell fails to prevent apoptosis at 
an early step, Shigella will block apoptosis at the level of caspase-3. Apoptosis inhibition is most likely vital to the 
survival of the bacteria in vivo. Future characterization of these host factors is required to fully understand how S. flexneri 
inhibits apoptosis in epithelial cells.
Background
Shigella flexneri is a Gram-negative, facultative intracel-
lular organism, and the causative agent of bacillary dysen-
tery. Infection with Shigella causes an intense acute
inflammatory reaction that leads to the destruction of the
colonic epithelium [1]. Clinical symptoms include watery
diarrhea, severe abdominal pain, and bloody, mucoid
stools. These symptoms of dysentery are due to the pene-
tration of Shigella into colonic epithelial cells, which pro-
vide an intracellular environment for the bacteria to
multiply and spread to adjacent cells [1]. Entry into epi-
thelial cells is mediated by the Ipa proteins encoded on
the 220-kb virulence plasmid. Secretion of these proteins
is dependent on a type III secretion system (T3SS), which
is encoded by 20 genes in the mxi-spa locus of the viru-
lence plasmid. Additional T3SS effector proteins are
secreted through the T3 needle when the bacteria are
inside the cytoplasm of the host cell [1].
We previously demonstrated that S. flexneri inhibits
apoptosis in epithelial cells [2]. Apoptosis, or pro-
grammed cell death, is a form of cell death that occurs
without damage or lysis to neighboring cells [3]. The
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Page 2 of 18intrinsic pathway of apoptosis is induced by various stim-
uli that leads to cytochrome c release from the mitochon-
dria and activation of the caspase cascade while the
extrinsic pathway of apoptosis is induced by cytokine
receptors of the tumor necrosis factor (TNF) family [3].
In the presence of staurosporine (STS), a chemical
inducer of the intrinsic pathway of apoptosis, S. flexneri
inhibits apoptosis by preventing the activation of cas-
pase-3 despite the fact that both cytochrome c release
from the mitochondria and caspase-9 activation occur
[2]. Given these findings, we next wanted to determine
the important cellular changes that occur in epithelial
cells upon infection with S. flexneri and subsequent expo-
sure to STS. Previous research analyzed changes in
eukaryotic gene expression due to S. flexneri invasion
using whole genome arrays [4]; however, analysis in the
presence of an apoptosis inducer has not performed.
Therefore, the goal of this paper was to identify the
changes in apoptosis-specific genes due to S. flexneri
invasion both in the presence and absence of STS. This
analysis will not only enhance our understanding of how
S. flexneri survives inside epithelial cells, but also allow us
to fully understand the mechanisms of protection from
apoptosis by identifying the host factors involved in this
process. The microarray analysis revealed distinct expres-
sion profiles in uninfected and infected cells, and these
changes were altered in the presence of staurosporine.
Based on these profiles, we made several comparisons
between the treatment groups. Compared to uninfected
cells, we found numerous alterations in host factors,
including the jun oncogene, inhibitor of apoptosis gene
family members, nuclear factor κB (NF-κB), and genes
involving tumor protein 53 and the retinoblastoma pro-
tein, all of which are important for the pro-survival state
of the infected cell. These data indicate that upon infec-
tion, the bacteria utilize multiple checkpoints along both
pathways to prevent apoptosis. If Shigella fails to inhibit
apoptosis at an early step, the bacteria will block apopto-
sis at the level of caspase-3. This inhibition is vital for the
bacteria to survive in vivo.
Results and Discussion
The treatments for the microarray analysis were selected
based on published observations that Shigella-infected
HeLa cells do not undergo apoptosis in the presence of
STS while uninfected HeLa cells undergo apoptosis in the
same conditions [2]. The bacteria were also able to inhibit
apoptosis in the colonic T84 cell line (data not shown).
The temporal strategy and length of STS exposure times
and infection were chosen to highlight key points in the
apoptosis pathway. These key points include the activa-
tion of pro-apoptotic proteins preceding damage to the
mitochondria (0.5 to 1 hour STS incubation), cytochrome
c release from the mitochondria (2 hour STS incubation),
and activation of caspase-3 before significant damage to
the HeLa nuclei (2.75 hour STS incubation).
To phenotypically verify that these incubation times
mirrored the above expectations, we exposed uninfected
HeLa cells to STS for 1, 2, or 3 hours and then performed
immunofluorescence analysis (Figure 1A). After 1 hour of
STS treatment, cells were stained with an antibody
against the Bad protein to detect total levels of the pro-
tein (Figure 1A). Phosphorylation of Bad promotes bind-
ing to 14-3-3 proteins, which prevents the pro-apoptotic
function of Bad [5]. An antibody that recognizes only the
phosphorylated form of Bad yielded a weak signal (data
not shown). Therefore, the pro-apoptotic Bad protein
was active after 1 hour of STS treatment since the
dephosphorylated form of Bad was primarily detected.
Next, we tested for cytochrome c release from the mito-
chondria after 2 hours of STS treatment using a weak
permeabilization treatment so only cytochrome c
released from the mitochondria is stained and cyto-
chrome c retained in the mitochondria produces only a
weak signal [2]. The bright signal (Figure 1A) indicates
that cytochrome c release occurred after the 2 hours of
STS treatment. Finally, caspase-3 activation and nuclear
damage was assessed after 3 hours of STS treatment
using an antibody that recognizes only the activated form
of caspase-3 and the DAPI nuclear stain, respectively, as
previously described [2]. Caspase-3 activation with sub-
sequent DNA damage was detected after 3 hours of STS
treatment (Figure 1A). Control experiments verified that
a 2.75 hour STS incubation time was adequate for cas-
pase-3 activation without significant DNA damage (data
not shown). In addition, to highlight our previous report
that S. flexneri inhibits STS-induced apoptosis, we per-
formed the apoptosis assay with a strain of bacteria
expressing a green fluorescence protein (GFP) on a low
copy plasmid. After the 6 hour assay, the infected cells
were fixed and stained for activated caspase-3. As seen in
Figure 1B, the uninfected cell is positive for activated cas-
pase-3; whereas the adjacent infected cell only has a
bright green signal due to the GFP expression by the bac-
teria and lacks a signal for activated caspase-3. Control
experiments showed that the bacteria expressing GFP on
the low copy plasmid had the same growth rate as wild-
type bacteria (data not shown).
Based on these results, we chose to examine uninfected
and infected cells in the presence and absence of STS
using the strategy outlined in Figure 2. The 2.5-hour
incubation of Dulbecco's modified Eagle's medium
(DMEM) with 50 μg/ml gentamicin allows the intracellu-
lar population of bacteria to grow within the HeLa cells
[2]. All STS treatments were matched with treatment
controls in which no STS was added. After the treat-
ments, the RNA was harvested at the indicated times,
reverse transcribed, and prepared for hybridization as
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cific for apoptosis genes and contain approximately 20
000 spots representing 451 genes. The resulting microar-
ray data were collated using the Stanford Microarray
Database and utilized for pairwise analysis using the Sta-
tistical Analysis for Microarrays (SAM) algorithm and the
student's two-tailed t-test to identify genes showing sig-
nificant changes in expression.
Additional file 1, Table S1 provides the data for all spots
that showed statistically significant differences in the
indicated pairwise analyses, and the complete data set is
available at http://smd.stanford.edu. We performed four
pairwise comparisons to identify key differences between
the treatment groups, and in-depth discussion of these
comparisons is provided below. The individual time
points were grouped together and then utilized as a single
group in the pairwise comparison. While this approach
has the limitation of overlooking transient changes in
host gene expression, we chose this method of analysis to
identify the most consistent and significant changes since
we reasoned that these changes would be vital for apop-
tosis inhibition during the entire six hours of infection.
Additionally, due to cost limitations we chose to use one
replicate of the experiment for microarray analysis and
the other replicate for in situ hybridization (ISH) analysis.
While this experimental design and the lack of a microar-
ray replicate prevented statistical analysis using ANOVA,
we were able to perform pairwise comparisons across
variable pairs using SAM and the student's two-tailed t-
test. While the analyses in the absence of a replicate are
less than ideal, we compensated for this by performing
extensive ISH analysis to confirm the most important
changes detected in the microarray data. Additional file
2, Table S2 provides the list of genes in all comparisons
categorized by function and provides brief descriptions of
gene function obtained from NCBI's Entrez Gene. Clus-
ter analysis of significantly changed genes across the
treatment groups revealed that the arrays segregate into
Figure 1 Immunofluorescence analysis of HeLa cells treated with STS. A. Uninfected cells stained with antibodies against key points in the STS-
induced apoptosis pathway, namely Bad activation at 1 hour, cytochrome c release at 2 hours, and activated caspase-3 and DNA damage with DAPI 
nuclear staining at 3 hours STS treatment. B. A monolayer of HeLa cells was infected with Shigella harboring a low copy number plasmid expressing 
GFP to allow green fluorescence. Left: Merged image of the monolayer for GFP and the activated form of caspase-3. Only the uninfected cells have a 
positive signal for caspase-3 activation. Right: Phase contrast view to visualize the bacteria in the cytoplasm of the HeLa cell. Images are representative 
of three repeated experiments, and cell counts of at least 300 cells for each treatment demonstrated consistent results (data not shown).
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uninfected cells away from infected cells. Within the
uninfected node, uninfected cells treated with STS segre-
gate away from uninfected cells that did not receive STS
treatment. However, this is not the case with infected
samples; STS treated samples are interspersed with
untreated samples across the node. This microarray anal-
ysis highlights clear differences in the expression of apop-
totic genes in infected cells compared to uninfected cells,
and interestingly, STS does not affect this pattern of
apoptotic gene expression in infected cells. This analysis
has provided insight into the strategies employed by S.
flexneri to inhibit apoptosis in infected epithelial cells.
Uninfected HeLa cells with STS compared to uninfected 
HeLa cells
There were 122 genes whose expression was significantly
altered in uninfected cells treated with STS (USTS) versus
uninfected cells (U). Interestingly, all 122 genes were
repressed, which indicates that the cells receiving STS
treatment turned off most gene expression during apop-
totic death and suggests that the pro-apoptotic proteins
already available in the cell are sufficient to induce death
Figure 3 Cluster diagram of significant genes across treatment 
groups. Cluster diagram of the genes showing statistically significant 
differences in uninfected (UN) or wildtype-infected (WT) HeLa cells 
treated with or without staurosporine (STS) for the given time points. 
Red and green colors represent increased or decreased expression, re-
spectively, relative to the reference sample. Note the dendogram, 
which displays the relationship of each treatment, shows two major 
nodes that segregate the majority of uninfected samples from wild-
type-infected samples. The color scale represents the fold change from 
the reference for induced and repressed expression.
Figure 2 Schematic of the infections and treatment conditions used in this study. A. The infection and STS treatment conditions were modified 
to analyze a time course of STS exposure and adapted from the apoptosis assay previously described [2]. Briefly, S. flexneri was applied to a monolayer 
of HeLa cells and incubated at 37°C for 1 hour in Dulbecco's modified Eagle's medium (DMEM). Afterwards, the cells were washed and DMEM plus 50 
μg/ml gentamicin was added to kill the extracellular bacteria and allow the intracellular bacteria to replicate. Uninfected cells received the same treat-
ments and washes. Finally, infected and uninfected cells were washed and received DMEM plus gentamicin or DMEM plus gentamicin and 4 μM STS 
for 0.5, 1.0, 2.0, or 2.75 hours. After the treatments, the RNA was harvested from the cells. Two biological replicates were performed: one set for the 
microarray studies and one set for in situ hybridization (ISH) studies to confirm the microarray results. A single time point was analyzed for the ISH (see 
Methods). B. The individual time points were grouped together and then utilized as a single group in the pairwise comparisons for the microarray 
analysis. The four pairwise comparisons performed are indicated.
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pases, DNA repair enzymes, p53-associated genes, pro-
apoptotic, and pro-survival genes (Additional file 2, Table
S2).
Shigella-infected HeLa cells compared to uninfected HeLa 
cells
The analysis identified a total of 137 induced genes and 3
repressed genes in wildtype-infected HeLa cells (WT)
compared to uninfected cells (U). In general, infected
cells are in a pro-survival state compared to uninfected
cells due to significant induction of various genes impor-
tant for apoptosis inhibition (see Figure 4). First, there
was a significant induction (17-fold) of JUN (also known
as c-JUN or AP-1), which is a transcription factor and an
oncogene [6]. The p38 MAPK and JNK signaling cascades
induce JUN in response to pro-inflammatory cytokines
and genotoxic stress. Upon activation, JNKs translocate
to the nucleus to phosphorylate and enhance the tran-
scriptional activity of JUN [7]. JUN has both pro-apop-
totic and pro-survival gene targets, and it is hypothesized
Figure 4 Model of apoptosis inhibition by Shigella flexneri at multiple checkpoints in epithelial cells. Infection of epithelial cells by S. flexneri 
results in several levels of protection from apoptosis. First, the bacteria prevent cytochrome c release from the mitochondria through the upregulation 
of BCL-2 proteins. Second, the extrinsic pathway of apoptosis is inhibited from in vivo stimuli such as TNF-α and FasL. This inhibition is most likely due 
to the upregulation of proteins like CFLAR, TNFAIP3, TNFAIP8, and FAIM3. Third, infection leads to the induced expression of JUN and NF-κB, which 
has many pro-survival effects including the increased expression of the IAPs (BIRC4, BIRC1, BIRC5, and BIRC7), the Bcl-2 family, and caspase-8 inhibitors. 
Finally, the bacteria prevent caspase-3 activation to provide downstream protection in the presence of strong apoptosis inducers. Through the use 
of T3SS effector proteins, the bacteria could directly generate mitochondrial protection, the inhibition of the extrinsic pathway, and caspase-3 inhibi-
tion. Alternatively, S. flexneri could indirectly produce these changes through the upregulation of pro-survival factors like JUN and NF-κB.
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mines whether the cell survives or undergoes apoptosis
[7]. Lipopolysaccharides (LPS) are the major component
of the outer membrane of Gram-negative bacteria, and
have been shown to induce the expression of JUN [8,9]. It
is therefore not surprising that the induction of JUN is so
robust in WT cells. However, we cannot rule out the pos-
sibility that a bacterial T3SS effector protein expressed
intracellularly also contributes to the induction of JUN.
Similar induction was also seen in a previous microarray
analysis of Shigella-infected cells [4]. Below we provide
evidence that WT cells are in a pro-survival state, some of
which may be due to JUN induction. JUN targets include
cyclins, E2F transcription factors, Ras-GRF1 (a guanine-
nucleotide exchange factor), and p53 [6,10-12]. Given
that there is a significant increase in JUN expression, per-
haps JUN is a major contributing factor to the pro-sur-
vival state of the infected cell. Future studies involving
small interfering RNA (siRNA) to knock down JUN
expression in infected cells will allow us to determine if
JUN induction upon infection is essential for the pro-sur-
vival state of the cell. Moreover, we predict that S. flexneri
mutants that are unable to inhibit apoptosis may not
induce JUN to the extent seen in WT cells.
Surprisingly, we found multiple upregulated genes that
are responsible for inhibiting apoptosis via the extrinsic
pathway (Table 1 and Figure 4). This result implies that
some of the apoptotic signals that occur during infection
activate the extrinsic pathway of apoptosis. Signals that
activate this pathway include tumor necrosis factor-α
(TNF-α) and Fas ligand [13,14]. TNF-α-induced protein 8
(TNFAIP8) was induced in infected cells and can inhibit
the TNF-α activation of caspase-8 [15]. TNFAIP3,
FAIM3, and CFLAR/c-FLIP inhibit caspase-8 activation
[16-18] and all had significant induction in infected cells.
Interestingly, TNFAIP3, also known as A20, was also
induced in a previous microarray analysis of Shigella-
infected cells [4]. Based on the array results, we examined
the ability of the Shigella to inhibit the extrinsic pathway
of apoptosis (Figure 5). Using TNF-α-related apoptosis
inducing ligand (TRAIL), which functions like TNF-α in
the apoptosis assay, infected cells were able to inhibit
apoptosis induction as seen upon nuclear staining.
Therefore, the upregulation of genes required for the
inhibition of the extrinsic pathway of apoptosis may be an
important aspect for S. flexneri to inhibit apoptosis in
vivo.
Other important genes induced in infected cells are
members of the inhibitor of apoptosis (IAP) family.
Expression of several IAP genes was significantly induced
(Table 1). IAP upregulation has previously been observed
in Shigella-infected cells using whole genome arrays [4].
The IAP family directly inhibits caspases [19], and cas-
pase-3 activation is inhibited in Shigella-infected cells in
the presence of STS [2]. The IAPs may be directly
involved in preventing caspase-3 activation in infected
cells treated with STS. On the other hand, if the IAP pro-
teins are not directly involved in inhibition of caspase-3
activation in infected cells in the presence of STS, the
induction of these genes could still be important to
enhance the pro-survival state of the infected cell. An
example is the ability of cIAP-1 to inhibit TRAF2 in TNF-
α-induced apoptosis [19].
Several genes that encode proteins that associate with
the mitochondrial membrane were induced in WT
infected cells. For example, BCL2 was induced and is
important for preventing permeabilization of the mito-
chondrial membrane [20]. Thus, the bacteria may utilize
T3SS effector proteins to increase BCL2 expression to
protect the mitochondria (Figure 4). Of note, the induc-
tion of BCL2 does not overcome the effects of STS since
cytochrome c release is observed in infected cells treated
with STS (see below and [2]). However, STS is a strong
apoptosis inducer, and the induction of BCL2 in infected
cells may be sufficient to prevent cytochrome c release in
the absence of STS. The bacteria may encode T3SS effec-
tor proteins that target the mitochondria or pro-survival
proteins, like BCL-2. These potential T3SS effectors
would not be able to overcome the effects of STS, but
would act as accessory proteins to enhance the pro-sur-
vival state of the cell. The increased expression of BCL2
and other genes important for protecting the mitochon-
drial membrane may also be a result of other pro-survival
effects (see below). Interestingly, BECN1 expression was
also induced and BECN1 has been shown to interact with
BCL-2 in viral infected cells, leading to apoptosis protec-
tion [21]. Therefore, the increased expression of BCL2
and BECN1 could promote protection of Shigella-
infected cells from apoptosis.
Additional genes that were induced in infected cells
include genes important for DNA replication and repair,
and cell cycle progression (Additional file 2, Table S2).
XRCC4, XRCC5, ERCC2, RAD17, and RAD51, which are
all key genes in DNA replication and repair [22-25], were
induced. DNA damage is a signal for apoptosis [26] and
maintenance of DNA integrity is an important aspect in
the inhibition of apoptosis. In addition to these genes,
there were also alterations in expression of genes involved
in cell cycle progression or arrest in WT infected cells.
One of the few repressed genes was SPATA4, which may
be important for the S/G2 transition [27]. However,
CUL2 and PPP2R1B were induced, and both promote cell
cycle arrest [28-31]. Other genes important for cell cycle
progression, including E2F3 and TFDP2, are induced
[32,33]. As mentioned above, E2F transcription factors
are regulated by JUN. The surprising changes in expres-
sion in genes that both promote and prevent cell cycle
progression may reflect a complex interplay between the
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strated that the Shigella effector IpaB interacts with
Mad2L2, leading to cell cycle arrest [34]. The authors
speculate that since intestinal epithelial cells undergo
rapid cell turnover, the bacteria promote cell cycle arrest
to maintain infection; infected cells under cell cycle arrest
resist apoptosis induction, since the cells are TUNEL-
negative [34]. These results validate our observations that
S. flexneri inhibits apoptosis. Conversely, cell cycle arrest
can lead to apoptosis especially in the absence of the
retinoblastoma tumor suppressor protein (pRb) [35]. Our
lab has recently reported that the S. flexneri effectors
OspF and OspB interact with pRb to modulate the
immune response [36]. This interaction could also pro-
tect pRb from degradation, which would allow cell cycle
arrest without leading to apoptosis. The attempt to arrest
the cell cycle and the potential protection of pRb enable
the bacteria to exploit cell cycle arrest and prevent apop-
tosis at the same time.
Finally, various genes were induced that correlate with
prior observations in S. flexneri infection. First, ELMO1
was induced in infected cells. The Shigella effector IpgB1
binds to ELMO1 to stimulate Rac1 activity, which
induces membrane ruffling during invasion of epithelial
cells. Therefore, IpgB1 acts as a molecular mimic of RhoG
[37], and the induction of ELMO1 is most likely a result of
the invasion process by the bacteria. Next, the S. flexneri
effectors IpgB2 and OspB are important for nuclear fac-
tor-kappa B (NF-κB) activation in infected cells [37,38].
The genes encoding NF-κB and proteins required for NF-
κB activation were induced in infected cells (Additional
file 2, Table S2 and Figure 4), including NFKB2. NF-κB
activation is important for inducing the expression of
pro-survival proteins such as TNFAIP8 [15], TNFAIP3
[16], CFLAR [18], and IAPs [39,40], which are induced in
infected cells as mentioned above. In addition, CARD15,
also known as NOD2, was upregulated in infected cells.
Nod2 recognizes muramyl dipeptide of peptidoglycan
from intracellular pathogens and activates NF-κB [41,42].
Even more important, Nod2 is also involved in the activa-
tion of the JNK pathway [43], which can lead to JUN acti-
vation. Therefore, NF-κB is a significant host factor
involved in inducing a pro-survival state in the infected
cell. Lastly, escape from autophagy is an important aspect
of S. flexneri infection. Atg5 binds the bacterial protein
VirG/IcsA and would normally induce autophagy; how-
Table 1: A selection of upregulated genes in wildtype-infected cells compared to uninfected cells.
Gene Function Fold Induction
Association with the inhibition of the extrinsic pathway of apoptosis
TNFAIP3 aka A20; inhibits TNF-alpha-induced apoptosis by inhibiting caspase-8 cleavage 9.3
TNFRSF12A functions, in part, through the NF-κB pathway to up-regulate BCL-XL and BCL-W 
expression for malignant cell survival
5.1
CSE1L binds strongly to importin-alpha; highly expressed in tumor cell lines and may play a 
role in inhibiting TNF-mediated cell death
3.1
FAIM3 Fas apoptotic inhibitory molecule 3; inhibits caspase-8 processing 2.7
BAG4 associates with TNFR1 and death receptor-3 to negatively regulate downstream death 
signaling
2.6
CFLAR CASP8 and FADD-like apoptosis regulator; aka c-FLIP; interacts with FADD and FLICE; 
inhibits apoptosis via human death receptors
2.5
FAIM Fas apoptotic inhibitory molecule; pro-survival; mediates Fas resistance produced by 
surface Ig engagement in B cells
2.1
PEA15 a death effector domain (DED)-containing protein; inhibits both TNFRSF6 and 
TNFRSF1A-mediated CASP8 activity & apoptosis
2.1
TNFAIP8 tumor necrosis factor, alpha-induced protein 8; inhibits the activated form of caspase-8 2.1
Interaction with caspases (IAP genes)
BIRC4 aka XIAP; inhibits apoptosis through binding to TRAF1 and TRAF2; also inhibits 
caspase-3 and caspase-7
3.5
BIRC1 aka NAIP; homology to two baculoviral IAPs; suppresses apoptosis induced by various 
signals; binds caspase-9
3.2
BIRC5 aka survivin; with hepatitis B X-interacting protein (HBXIP) binds caspase-9; variant 
DeltaEx3 binds caspase-3 with BCL-2
2.8
BIRC7 aka livin; shown to interact with caspase-3, -7, & -9; degrades Smac/DIABLO 2.8
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VirG/IcsA [44]. While there was an induction of ATG12,
there was no subsequent induction in ATG5 or any other
gene important for autophagy. This result most likely
reflects the ability of the bacteria to escape autophagy.
Autophagy inhibition and apoptosis inhibition may be
connected [45]. Therefore, the blockage of autophagy in
infected cells is likely critical for Shigella to survive inside
epithelial cells.
In summary, Shigella-infected cells are in a pro-survival
state compared to uninfected cells, and a major contrib-
uting factor to this state most likely was the induction of
JUN. Genes important for blocking the extrinsic pathway
of apoptosis were also induced, in addition to the IAPs,
DNA repair enzymes, and genes important for NF-κB
activation. Moreover, the changes in gene expression seen
in infected cells can be correlated to known effects of var-
ious T3SS effector proteins. The pro-survival state of
infected cells may be required for apoptosis inhibition in
infected cells in the presence of strong inducers like STS.
At the least, the induction of these pro-survival genes
may facilitate a T3SS effector protein to directly inhibit
caspase-3 activation in the presence of STS.
Shigella-infected HeLa cells treated with STS compared to 
uninfected HeLa cells treated with STS
There were 167 induced and 6 repressed genes in wild-
type-infected cells treated with STS (WTSTS) compared
to uninfected cells treated with STS (USTS). Among
these, there were 72 genes that show the same differential
expression, either induced or repressed, as in the U versus
WT comparison (Figure 6). However, some of the levels
of expression do vary. For example, JUN was induced
even more under WTSTS conditions; a 27-fold induction
was observed. This increase in induction compared to
WT cells is most likely a direct result of the addition of
STS to the infected cells. Interestingly, FOSL2 or FRA-2
was induced here but not in the U versus WT compari-
son. FOSL2 is a part of the AP-1 transcription factor
complex and has been shown to dimerize with JUN [46].
Moreover, LTBP3 was induced here but not in the U ver-
sus WT comparison. LTBP3 is important in the activa-
tion of transforming growth factor-β (TGF-β) and has an
AP-1 binding site in the promoter region [47]. TGF-β can
lead to cell cycle arrest, but it has also been shown to be
important in tumor progression [48,49]. Thus, the
increase in magnitude of JUN expression seen in WTSTS
could lead to the induction of FOSL2 and LTBP3 seen in
these cells.
Figure 5 Infected cells resist apoptosis induction via the extrinsic pathway. Uninfected and wildtype-infected cells analyzed in the apoptosis 
assay treated with TRAIL. Top: DAPI stain of uninfected (left) and infected (center) cells treated with TRAIL. Note the uninfected cells have characteristic 
apoptotic nuclei while the infected cell, in which the bacteria are also stained with the DAPI, has a healthy nucleus. An uninfected cell without TRAIL 
treatment appears on the right. Bottom: Phase contrast view of the cells. The infected cell, in which the bacteria are visible in the cytoplasm, has a 
healthy, round appearance while the uninfected cells are apoptotic. Images are representative of three repeated experiments, and cell counts of at 
least 300 cells demonstrated that infected cells consistently appeared healthy (data not shown).
Faherty et al. BMC Genomics 2010, 11:272
http://www.biomedcentral.com/1471-2164/11/272
Page 9 of 18Another example of increased expression due to the
STS was seen in the induction of NFKBIA; there was
approximately a 7-fold increase in WTSTS cells com-
pared to a 3-fold increase in the U versus WT compari-
son. NFKBIA is an inhibitor of NF-κB since it helps to
trap NF-κB in the cytoplasm [49]. The induction of NFK-
BIA might be a response to the increased levels of NF-κB
due to infection, or might be a direct effect of STS. How-
ever, the induction of this gene does not affect the expres-
sion of NFKB2 in WTSTS cells since NFKB2 has about
the same level of expression as WT cells in the U versus
WT comparison.
Remarkably, approximately the same anti-apoptosis
genes are induced in conditions with STS compared to
the above conditions without STS suggesting the same
pro-survival state of the cell was induced upon infection
regardless of the presence of STS. However, there are
some key differences, given the fact that the bacteria
inhibit apoptosis in the presence of the strong inducer
STS. The only IAP induced was BIRC2 (Additional file 2,
Table S2). BIRC2 encodes cIAP1, which is involved in
inhibiting caspase-8 activation [39]. Interestingly, there
was no induction of BIRC4/XIAP. Since BIRC4/XIAP
inhibits caspase-3 activation [19], utilization of this IAP
may not be important for the bacteria to inhibit caspase-3
activation in the presence of STS. Additionally, it is
unlikely that the bacteria are using the XIAP already
made without needing further significant production of
the protein in the presence of STS over a three-hour time
period. Therefore, we hypothesize that either the bacteria
use a T3SS effector protein to directly inhibit caspase-3
activation in the presence of STS, or that the bacteria
indirectly block caspase-3 activation by upregulation of
other pro-survival genes. For example, genes required for
NF-κB activation were again induced in WTSTS cells
(Additional file 2, Table S2), leading to the same pro-sur-
vival effects outlined above. Interestingly, TRAF2 was
induced in WTSTS, and this induction was not seen in
the U versus WT comparison. TRAF2 is important for
caspase-8 activation and is induced by NF-κB [39]. In
addition, TRAF2 can activate the JNK pathway via
MEKK1 leading to JUN induction [50]. Also in support of
protection through NF-κB, IER3 was induced in WTSTS
cells compared to USTS cells. IER3, also known as IEX-
1L, is involved in protecting cells from TNF-induced
apoptosis, and IER3 is regulated by NF-κB [51]. Addi-
tional possibilities for the inhibition of caspase-3 in the
presence of STS include the repression of pro-apoptotic
pathways (see below). Once we identify the bacterial pro-
tein required for apoptosis inhibition, we can investigate
how this protein functions in the eukaryotic cell.
There were two genes that appear in both sets of com-
parisons but show opposite directions of expression.
First, NALP1 was induced in U versus WT but repressed
in USTS versus WTSTS. NALP1 is part of the inflam-
masome in which pro-inflammatory caspase-1 activation
leads to interleukin-1β (IL-1β) processing, especially in
the presence of LPS [52]. NALP1 is suppressed by BCL-2
and BCL-XL to reduce caspase-1 activation and IL-1β
production [53]. BCL2 was induced in WTSTS cells (see
below). The Shigella effector IpaB binds and activates
caspase-1 in macrophages, leading to IL-1β secretion and
cell death via pyroptosis [1]. There have not been any
studies regarding IpaB and caspase-1 activation in epithe-
lial cells. While it may not be the primary method of
apoptosis inhibition, NALP1 repression or inhibition of
NALP1 by BCL-2 may be an important mechanism for
the pro-survival state of the infected epithelial cell in the
presence of STS. This finding may be a crucial explana-
tion for the differences in bacterial-induced cell death in
macrophages and bacterial-induced cell survival in the
epithelial cells. Second, EDARADD was repressed in U
versus WT while it was induced in USTS versus WTSTS.
EDARADD acts as an adaptor protein for EDAR to
recruit TRAF2 proteins during NF-κB activation [54,55].
This induction of EDARADD possibly enhances the pro-
survival effect of NF-κB activation in the presence of STS
as described above.
The comparison between USTS to WTSTS treatments
revealed numerous differences in p53-associated genes
and pRb-associated genes that were not seen in the U ver-
sus WT comparison (Table 2). p53 is a transcription fac-
tor and tumor suppressor, and can induce apoptosis by
activating various targets that lead to mitochondrial per-
Figure 6 Venn diagram comparing Uninfected versus Wildtype-
infected to Uninfected cells treated with staurosporine versus 
Wildtype-infected cells treated with staurosporine. There is a total 
of 140 differentially expressed genes in uninfected cells (U) compared 
to wildtype-infected cells (WT). Of those 140 genes, the same 72 genes 
were differentially expressed in uninfected cells treated with STS 
(USTS) compared to wildtype-infected cells treated with STS (WTSTS). 
The USTS vs. WTSTS comparison has a total of 173 differentially ex-
pressed genes.
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Page 10 of 18meabilization [56,57]. p53 itself was not altered in USTS
versus WTSTS, and JUN is known to be a direct repres-
sor of p53 [7]. Therefore, the induction of JUN most likely
had a significant effect on the expression of p53 in
infected cells. However, TP73L or TP63, a homolog to
p53 that can induce apoptosis by activating pro-apoptotic
genes including BAX, APAF1, and caspase-9 [57], had
increased expression in WTSTS cells. The induction of
TP63 most likely lead to the increased expression of BAX,
APAF1, and caspase-9 seen in WTSTS cells. However,
increased levels of these proteins and the subsequent
activation of the proteins by STS had no effect on
WTSTS cells since S. flexneri inhibits apoptosis after cas-
pase-9 activation [2]. Interestingly, TP63 can also induce
caspase-8 and caspase-3 [57], but these genes were not
induced in WTSTS cells. Finally, many genes, in which
the gene products affect p53, were upregulated. For
example, TP53BP2 was induced in WTSTS cells.
TP53BP2 is a part of the apoptosis-stimulating protein of
p53 (ASPP) family of p53-interacting proteins and
enhances p53 binding to DNA for transcriptional activa-
tion of pro-apoptotic genes [58]. Also, PPP2CA, which
was induced in WTSTS cells, induces the expression of
p53 and can lead to G2/M cell cycle arrest [59]. P53AIP1
was induced in WTSTS cells compared to USTS cells,
and is a p53-dependent gene whose gene product binds
BCL-2 to cause cytochrome c release from the mitochon-
dria [60]. Due to the mitochondrial permeabilization of
Shigella-infected cells in the presence of STS, it is not sur-
prising that these p53-regulated genes were induced.
Despite the induction of p53-responsive genes, p53 itself
was not induced in WTSTS or in WT cells most likely
due to significant JUN induction since JUN represses p53.
There were also induced genes in WTSTS cells that are
responsible for suppressing p53 in addition to JUN. These
genes include JUND [61], CUL4A [62], and NEDD8 [63]
(Additional file 2, Table S2). JunD, which is in the AP-1
transcription factor complex like JUN, is also important
Table 2: A selection of upregulated genes in wildtype-infected cells with staurosporine compared to uninfected cells with 
staurosporine.
Gene Function Fold Induction
Association with p53
TP53BP2 a member of the ASPP (apoptosis-stimulating protein of p53) family of p53 
interacting proteins
3.3
TP73L aka tumor protein p63; homolog to p53 3.1
JUND member of the JUN family; a component of the AP1 TF complex; proposed to protect 
cells from p53-dependent senescence and apoptosis
2.8
P53AIP1 P53-regulated apoptosis-inducing protein 1; p53AIP1 regulates the mitochondrial 
apoptotic pathway
2.7
CUL4A functions as an E3 ligase & with MDM2, contributes to p53 degradation; assists in 
nucleotide excision repair in a complex with DDB
2.6
LRDD interacts FADD & MADD; may function as an adaptor protein in cell death-related 
signaling processes; a p53 effector (induces apoptosis)
2.5
NEDD8 similar to ubiquitin; conjugated to p53 via MDM2, thereby inhibiting the 
transcriptional activity of p53
2.2
PPP2CA the phosphatase 2A catalytic subunit; inhibits cell growth and activates p53 & p21 
(p53-responsive); overexpression leads to G2/M arrest
2.2
MDM4 contains a RING finger domain & a putative nuclear localization signal; interacts with 
p53 (stabilizes to counteract MDM2)
2.0
Association with pRB
RBBP4 involved in chromatin remodeling & transcriptional repression associated with 
histone deacetylation; binds directly to pRB
3.7
JARID1A aka RBBP2; binds with pRB for tumor suppressive functions; may interact with 
rhombotin-2
2.7
RBBP5 a ubiquitously expressed nuclear protein; binds pRB, which regulates cell 
proliferation
2.3
RBBP6 binds to unphosphorylated but not phosphorylated pRB; also binds p53; blocks 
suppression of adenoviral E1A protein
2.0
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the expression of JunD, and JunD acts with NF-κB to
increase the expression of cIAP2 [64]. GADD45 (or
GADD45A) which is a p53-responsive gene that recog-
nizes damaged chromatin and facilitates topoisomerase
cleavage activity to cause DNA damage [65], was induced
approximately 10-fold in WTSTS cells. In addition,
GADD45A expression may be regulated by AP-1 com-
plexes containing JunD [66]. This induction may be a
result of the high induction levels of the genes associated
with AP-1 complexes, namely JUN, JUND, and FOSL2.
The pro-apoptotic phenotype of GADD45A does not
affect WTSTS cells. Another gene that is responsible for
suppressing p53 and directly degrades the protein,
MDM2 [67], was induced in WTSTS cells. The induction
of genes important for enhancing and suppressing p53
most likely represents an attempt by the cell to undergo
apoptosis in the presence of STS, especially since p53
enhances cytochrome c release from the mitochondria
[56]. Conversely, the bacteria are inhibiting apoptosis and
inducing a pro-survival state of the cell, which most likely
explains the induced expression of genes responsible for
suppressing p53. Interestingly, MDM2 was induced in the
U versus WT comparison in addition to the significant
induction of JUN. The bacteria may directly upregulate
MDM2 expression or the upregulation could be a
response of the eukaryotic cell to the pro-survival state
seen.
pRb-associated genes occur more in the USTS versus
WTSTS comparison than in the U versus WT compari-
son. The RBBP4, RBBP5/RBQ-3, RBBP6, and JARID1A or
RBBP2 genes were all induced in WTSTS cells and are
important for pRb function [68-71]. In fact, RBBP4 is
repressed in cervical cancer due to human papillomavirus
infection [69]. RBBP6 has been shown to bind p53, inhibit
adenoviral E1A from binding pRb, and may have a ubiq-
uitin-like domain [72]. In addition, SERPINB2, which
represses pRb pro-apoptotic signal transduction [73], was
induced in WTSTS cells. As mentioned above, the bacte-
ria may require pRb function to prevent apoptosis while
attempting to cause cell cycle arrest. In support of this
hypothesis, there were even more genes induced in the
USTS versus WTSTS comparison that are involved in cell
cycle arrest or progression than the genes induced in the
U versus WT comparison. For example, CUL1, CUL3,
APPBP1, and ESPL1/ESP1 are induced. These genes are
important for regulation of the cell cycle [74-77]. The
observations further highlight the interplay between the
bacteria attempting to arrest the cell cycle while the
eukaryotic cell attempts to progress the cell cycle as
described above.
Finally, there were more induced genes whose gene
products are localized to the mitochondria in STS condi-
tions (Additional file 2, Table S2). For example, DIABLO
and HTRA2 were induced in WTSTS cells and encode
proteins responsible for inhibiting IAPs upon release
from the mitochondria [78]. The pro-apoptotic BAX,
BCL2L11, BID, BNIP3L, and BOK proteins [78] were all
induced in WTSTS cells as well. These pro-apoptotic
genes do not affect the inhibition of caspase-3 by Shigella,
especially since cytochrome c release occurs in the pres-
ence of STS in infected cells [2]. Finally, the pro-survival
BCL2L2 or BCL-W and GLRX2 [78,79] genes, in addition
to the induction of BCL2 and CYCS (encodes cytochrome
c) that also occurs in WT cells, were induced in WTSTS
cells. GLRX2 encodes glutaredoxin, which protects the
mitochondria from oxidative stress [79]. The induction of
these pro-survival genes most likely reflects an attempt of
the infected cell to repair or maintain mitochondrial
integrity during STS treatment of infected cells.
In summary, the changes in gene expression in the
USTS versus WTSTS comparison were similar to the
changes seen in the U versus WT comparison. Neverthe-
less, there were some key distinctions that include higher
levels of induction of some genes, opposite expression of
genes in the presence of STS, enhancement of the pro-
survival state related to NF-κB, induction of genes related
to p53 and pRb, and the induction of more genes associ-
ated with the mitochondrial membrane. The majority of
these changes most likely represent the pro-survival state
induced by Shigella, and these changes were enhanced
upon STS exposure. However, a few changes, including
the repression of NALP1, may have a direct role in apop-
tosis inhibition by Shigella.
Shigella-infected HeLa cells treated with STS compared to 
Shigella-infected HeLa cells
The purpose of this comparison was to measure the
changes in infected cells that are required for apoptosis
inhibition in the presence of STS. Surprisingly, the SAM
analysis revealed no significant genes. When the less
stringent student's t-test was used to analyze the data, we
did find changes in gene expression (Additional file 2,
Table S2); however, the fold changes were not as high as
the other comparisons. Approximately 80% of the
changes were less than two-fold and the highest induc-
tion or repression was approximately 3-fold. Thus, the
array results demonstrated that there were few significant
differences between the two conditions and suggested
that the bacteria induce the same pro-survival state in
infected cells regardless of the presence or absence of
STS. Therefore, STS has no overall significant effect on
infected cells. The cluster diagram in Figure 3 supports
this hypothesis since WT cells and WTSTS cells are
interspersed while U cells cluster away from USTS cells.
Also in support of this hypothesis, there was no change in
expression of JUN, BIRC2/cIAP1, TRAF2, or NFKB2. The
absence of changes in these key genes indicates that Shi-
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eukaryotic cell that is not altered by the presence of STS.
Of the few additional changes seen, it is interesting to
see that CASP10 was repressed in WTSTS cells com-
pared to WT cells. Caspase-10 is activated in the extrin-
sic pathway of apoptosis, and etoposide, a
chemotherapeutic agent and cytotoxic drug, induces
CASP10 expression in a p53-dependent manner [80,81].
In addition, caspase-10 is activated after cytochrome c
release to amplify caspase-9 and caspase-3 activation in
the presence of etoposide. In fact, caspase-10 activation
can be inhibited if cytochrome c release is inhibited.
More importantly, a dominant-negative form of caspase-
10 is able to inhibit the activation of caspase-3 in the
presence of etoposide [81]. Since S. flexneri inhibits cas-
pase-3 activation despite cytochrome c release in the
presence of STS, caspase-10 could be a eukaryotic target
for the bacteria to utilize to interfere with caspase-3 acti-
vation and inhibit apoptosis. Alternatively, p53 inhibition
could reduce caspase-10 levels, which demonstrates the
importance of the inhibition of p53 activity that occurs
during infection.
Finally, it is important to note that IKBKG/NEMO was
induced in the WTSTS cells compared to WT cells
(Additional file 2, Table S2). NEMO is the regulatory sub-
unit of the IκB kinase (IKK) complex that, when acti-
vated, phosphorylates the IκB proteins. Phosphorylation
leads to ubiquitination of IκB proteins, thereby releasing
NF-κB and allowing NF-κB to enter the nucleus for tran-
scriptional activation. In addition, cIAP1 ubiquitinates
NEMO in response to TNF-α stimulation, which is
required for NF-κB activation [82]. The upregulation of
NEMO is most likely the result of continued NF-κB acti-
vation in Shigella-infected cells in the presence of STS.
Nevertheless, this comparison highlights the fact that the
infected cell is under the same pro-survival state regard-
less of the presence or absence of STS. This strong apop-
tosis inducer, therefore, has little overall effect on the
infected cells.
In situ hybridization analysis to confirm the microarray 
results
We used in situ hybridization (ISH) analysis as previously
described [83] to quantify the mRNA expression of sev-
eral genes and to confirm the results of the microarray
analysis. ISH has been shown to be as sensitive as real-
time RT-PCR [84] and is therefore an appropriate method
to confirm the microarray results. Biologically indepen-
dent samples were collected and analyzed with biotin-
labeled probes representing genes that showed significant
fold changes in the microarray results, namely JUN,
TNFAIP3, NFKBIA, CASP10, NALP12, ERCC2, DNAJA3,
and CD38. As shown in Figure 7A, each probe showed
the same trend for the ISH analysis as was seen in the
microarray analysis, namely a significant increase in
expression of each gene in cells infected with bacteria as
indicated by a positive, brown staining reaction. For the
JUN probe, the same result was seen regardless of the
presence of STS. Repressed genes also had the same trend
for the ISH analysis as was seen in the microarray analysis
(Figure 7B). All reactions utilized a control in which PBS
was added in place of the probe. Additional controls
included DNase, RNase, or DNase plus RNase treatment
of the samples prior to the addition of the probes. These
treatments degrade the targets in the tissue while allow-
ing the probe to be applied to the sample, which ensures
that the brown reaction does not result from nonspecific
binding of the biotin-labeled probe. All controls were
negative for the peroxidase reaction (data not shown).
Therefore, the ISH analysis validates the microarray
results reported above.
Conclusion
The identification of the Shigella proteins required for the
inhibition of apoptosis and the mechanism by which the
proteins inhibit apoptosis will help define which changes
in eukaryotic gene expression are relevant for STS inhibi-
tion. However, the changes in eukaryotic gene expression
described here appear to be important for enhancing the
pro-survival state of the infected cell in the absence of a
strong apoptosis inducer like STS. Future studies will
define the importance of the induction of certain genes.
For example, siRNA studies to knock down JUN, the
IAPs, or NF-κB expression will help to determine which
changes are required for apoptosis inhibition upon infec-
tion. In addition, analysis of the extrinsic pathway of
apoptosis will allow us to determine if inhibition occurs
prior to caspase-8 or caspase-3 activation, as well as iden-
tify which proteins in Table 1 are involved. The altera-
tions in eukaryotic gene expression reported here are
important to fully understand how Shigella inhibits apop-
tosis in epithelial cells.
There are other bacterial pathogens that inhibit apop-
tosis [85] and some of these pathogens have been utilized
in similar microarray analyses to identify changes in
eukaryotic gene expression in infected cells. Studies with
Neisseria gonorrhoeae, which can inhibit STS-induced
apoptosis at the mitochondrial level, found two to eight-
fold upregulation of BFL-1, COX-2, MCL-1, and cIAP2 in
infected cells [86]. Mycobacterium tuberculosis is able to
induce cell death in alveolar macrophages while it can
prevent apoptosis in alveolar epithelial cells. M. tubercu-
losis infection of epithelial cells results in increased
expression of BCL2 and pRb, decreased expression of
BAX and BAD, and no change in p53 expression despite a
large increase in expression of p53 in infected mac-
rophages. In addition, the macrophages show significant
inhibition of pRb [87]. The p53 and pRb observations are
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Figure 7 Comparison of the microarray and in situ hybridization results. The log2 of the red/green ratio for the microarray analysis is plotted on 
the left for the specified probe while the volumetric density (Vvi) for the in situ hybridization (ISH) analysis is plotted on the right for the specified probe. 
For the microarray analysis, the data for each time point of treatment (refer to Figure 2) are plotted with a line representing the mean of the data. The 
bigger, light-colored squares represent the time points that correlate with the ISH data. For the ISH, the Vvi for 15 fields at 400× magnification for the 
single time point is plotted with a line representing the mean of the data. A student's t-test was performed on the ISH data, and all p-Values were < 
0.0001, indicating that there is a significant difference between uninfected cells and infected cells for the expression of each gene tested. The images 
represent some of the ISH reactions for the specified treatment condition and probe. Images were taken at 1000× magnification. U = uninfected cells, 
WT = infected cells, USTS = uninfected cells treated with staurosporine, and WTSTS = infected cells treated with STS. A: Induced genes. B: Repressed 
genes.
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epithelial cells, both in the presence and absence of STS.
Another similarity to Shigella infection is seen with the
pathogen Edwardsiella tarda, which upregulates NF-κB
target genes, including cIAP2 and TRAF1 in mac-
rophages [88]. Finally, analysis of Rickettsia rickettsii
infected endothelial cells in the presence of STS revealed
induced expression of TRAFs, many genes the products
of which localize to the mitochondria, several IAPs,
AKT1, and p53 [89]. Like the above pathogens, S. flexneri
induces similar changes in eukaryotic gene expression in
order to inhibit apoptosis. However, each pathogen is
unique in that it may employ a different method to inhibit
apoptosis. For example, while S. flexneri inhibits capsase-
3 activation, other pathogens like N. gonorrhoeae prevent
mitochondrial permeabilization. Despite these differ-
ences, a common theme has emerged in that the bacteria
induce a pro-survival state in infected cells, which results
in similar changes in eukaryotic gene expression.
Knowing that S. flexneri inhibits STS-induced apopto-
sis at the level of caspase-3 activation [2] and given the
changes in eukaryotic gene expression and resistance to
TRAIL-induced apoptosis reported here, we propose that
S. flexneri blocks apoptosis at multiple checkpoints in
infected cells (Figure 4). Upon infection of epithelial cells,
the bacteria either directly induce protection of the mito-
chondria by secreting T3SS effector proteins or indirectly
protect the mitochondria by upregulating several eukary-
otic genes including JUN, NFKB2, and BCL2. This possi-
bility is supported by the evidence that there is no
cytochrome c release upon normal infection with Shigella
[2]. Another level of protection induced upon infection is
resistance to inducers of the extrinsic pathway of apopto-
sis, such as TRAIL. Upregulation of TNFAIP3, TNFAIP8,
TNFRSF12A, FAIM3, and CFLAR are important to
inhibit caspase-8 activation, and may be direct targets of
Shigella T3SS effector proteins or result from NF-κB acti-
vation. It is important to inhibit apoptosis from the
extrinsic pathway since many in vivo stimuli are present
during infection such as TNF-α and Fas ligand [13,14].
Finally, the bacteria provide downstream protection and
directly inhibit caspase-3 activation to prevent apoptosis,
which is only evident when strong apoptosis inducers like
STS are used. This downstream block provides protec-
tion if the invading Shigella fail to inhibit apoptosis at
upstream checkpoints. While STS can overcome many of
the pro-survival effects like protection of the mitochon-
dria, the chemical cannot overcome the protection of cas-
pase-3 cleavage induced by the bacteria. In addition, the
upregulation of genes to suppress the effects of p53
enhance the pro-survival effects of the infected cell chal-
lenged with apoptosis inducers. Future experiments will
determine which bacterial T3SS effector protein(s) and
which eukaryotic genes are required for S. flexneri to
inhibit apoptosis. The evidence presented here clearly
shows that there are multiple steps required for Shigella
to successfully prevent apoptosis in infected epithelial
cells. Without this protection, Shigella would not have an
efficient means of survival in vivo.
Methods
Bacterial strains used and growth conditions
The strain used in the study was the wildtype S. flexneri
serotype 2a strain 2457T. Bacteria were routinely cul-
tured at 37°C either in Luria-Bertani broth (LB) with aer-
ation or on tryptic soy broth plates with 1.5% agar and
0.025% Congo red (Sigma).
Immunofluorescence analysis
After the varying STS exposures on the uninfected cells
(Figure 1), cells were fixed with 3% formaldehyde (36%
stock; Sigma) and 0.2% glutaraldehyde (25% stock; Sigma)
in 1× PBS for 5 minutes at 4°C. Immunofluorescence
analysis was performed as previously described [2]. For
Bad staining, a rabbit anti-Bad antibody (Cell Signaling
Technology) was used in conjunction with a goat anti-
rabbit immunoglobulin G (IgG) antibody conjugated to
Alexa-594 (Invitrogen). An additional antibody that rec-
ognizes the phosphorylated form of Bad (phospho-Bad
(Ser112), Cell Signal Technology) was also used with a
goat anti-mouse IgG antibody conjugated to Alexa-594
(Invitrogen). For the cytochrome c release staining, the
staining procedures were followed as described in the
protocol provided by Molecular Probes. For the activated
caspase-3 staining, a primary anti-human cleaved cas-
pase-3 antibody (Cell Signaling Technology) was used
with the same goat anti-rabbit secondary antibody above.
To visualize nuclei, 5 mg/ml of 4,6-diamido- 2-phenylin-
dole (DAPI; Molecular Probes) was diluted 1:1,000 in 1×
phosphate buffered saline (PBS) and added to the mono-
layers for 20 min at room temperature in the dark. For all
immunofluorescence experiments, antifade reagent
(Molecular Probes) was added before coverslips were
applied after the staining procedure. Samples were stored
in the dark at 4°C and analyzed with an Olympus BX60
fluorescence microscope with an attached digital camera
using ×100 magnification.
Apoptosis assay and RNA isolation
The apoptosis assay was performed in HeLa cells as pre-
viously described in which infections occurred at a multi-
plicity of infection of 100 bacteria per HeLa cell [2] and
the various treatment conditions are provided in Figure 2.
In both the presence and absence of STS, 90 percent
infection was achieved as previously demonstrated [2].
The STS exposure times were modified to reflect key
points in the apoptosis pathway (see Results and Discus-
sion). After the apoptosis assay, the monolayers were
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reagent. RNA was extracted from the TRIzol using chlo-
roform, precipitated using isopropyl alcohol, and cleaned
using the RNeasy kit (Qiagen). DNase treatment
occurred directly on the columns, and after washes, the
RNA was resuspended in 30 μl RNase-free water. The ref-
erence RNA for all hybridizations consisted of a pooled
sample of RNA isolated from normal, healthy HeLa cells.
The RNA concentration of the treatments and the refer-
ence was quantitated by determining the OD260 and the
RNA integrity of all the samples was analyzed on a 1%
agarose gel. All RNA was pure and not degraded by the
isolation procedure (data not shown).
The apoptosis assay was modified to investigate the
extrinsic pathway of apoptosis, which was also performed
in HeLa cells using recombinant tumor necrosis factor-α
related apoptosis inducing ligand (TRAIL, Calbiochem).
The apoptosis assay was performed as previously
described [2]. Simply, TRAIL was substituted for STS in a
three-hour incubation at a concentration of 3.4 μg/ml.
Microarray hybridization and analysis
The treatment RNA and reference RNA were concen-
trated to 5 μg RNA in 12 μl RNase-free water for cDNA
synthesis. The FairPlay III kit (Stratagene) was used for
preparing labeled cDNA with some modifications. 500
ng/μl random hexamer solution was used in the reaction,
and once the cDNA was synthesized, the treatments and
reference were purified using ethanol precipitation in
which the samples were placed at -20°C for 1 hour. Next,
the NHS-Ester containing dye coupling reaction was per-
formed according to the protocol. The reference and
treatment cDNA were subsequently indirectly labeled
with Cy3 (green) and Cy5 (red) fluorophores, respec-
tively. The samples were then purified to remove uncou-
pled dye, and the labeled cDNA was eluted in 50 μl of 10
mM Tris base, pH 8.5. The cDNA was analyzed via a
spectrophotometer to determine dye incorporation and
cDNA yield. The reference sample was mixed with each
of the treatments so that each treatment had 1 μg of
cDNA and 1 μg of reference cDNA. The samples were
concentrated in the speed vacuum on medium heat to 44
μl, and then 11 μl of 10× blocking agent (7.5 μl 10× Agi-
lent blocking reagent, 2 μl human COT-1 DNA (10 μg/
μl), 1 μl poly d(A)40-60 (8 μg/μl), 1 μl yeast tRNA (25 μg/
μl)) was added to the samples. The mixtures were heated
to 98°C for 2 minutes, cooled briefly, and the 2× hybrid-
ization buffer was added (HI-RPM, 55 μl), resulting in a
final volume of 110 μl for each sample. The samples were
loaded onto the ExonHit Therapeutics microarrays (451
apoptosis-specific genes) for hybridization at 65°C. After
overnight hybridization, the arrays were washed and
scanned using a 4000A scanner and the GENEPIX 3.0
software.
Data were collated using the Stanford Microarray Data-
base [90] in which spots showing obvious abnormalities
were excluded from the analysis and an uncentered met-
ric was used during the clustering. Treatment conditions
across all time points were grouped into a single condi-
tion, and each condition was then compared to the other
treatment conditions to reveal changes in eukaryotic
gene expression that are important for apoptosis inhibi-
tion in the presence of STS in Shigella-infected cells. This
grouping allowed us to identify changes in gene expres-
sion in only those genes showing the most consistent and
significant changes within each treatment group. The sig-
nificance analysis of microarray (SAM) program version
2.20 and the student's t-test with a p-value cutoff of less
than 0.01 were used to generate the list of significant
genes. The false discovery rate (FDR) of the four pairwise
comparisons did not exceed 3.1%. The genes in Addi-
tional file 2, Table S2 were categorized by function and/or
pathway using the gene descriptions provided by NCBI's
Entrez Gene. Figure 3 was generated by average linkage
clustering using the hierarchical clustering algorithm of
the Cluster 2.11.0.0 program.
In situ hybridization analysis
In situ hybridization (ISH) was performed as previously
described [83] with some modifications to confirm the
microarray results. Infections were performed in HeLa
cells with wildtype bacteria for 5.5 hours in DMEM plus
50 μg/ml gentamicin. When used, STS was applied at a 4
μM concentration for the last 2.5 hours of the assay.
Uninfected cells received the same treatments and incu-
bation times as infected cells in the appropriate compari-
sons. These time points were chosen to see the overall
effect of infection and/or STS exposure on the cells.
Afterwards, the HeLa cells were fixed with 3% formalde-
hyde (36% stock; Sigma) and 0.2% glutaraldehyde (25%
stock; Sigma) in 1× PBS overnight at 4°C. For the ISH
analysis, the probes and sequences used to generate the
probes are listed in Table 3. The probe sequences were
designed within the sequence of the corresponding
microarray probe, and anneal to the cDNA sequence of
the respective gene. All sequences are 32 nucleotides in
length, and these sequences were analyzed with BLAST
to ensure specificity to the gene target. All probes were
synthesized in the Synthesis and Sequencing Facility, Bio-
medical Instrumentation Center, Uniformed Services
University of the Health Sciences (USUHS; Bethesda,
Maryland). The 5' end of each oligonucleotide was
labeled with biotin. After probe hybridization, avidin-
conjugated peroxidase and 3,3'-diaminobenzidine (DAB)
tablets (Sigma) were used to detect the probes, which
results in a brown reaction. Finally, the samples were
counterstained with hematoxylin QS (Vector) to visualize
the cells and were mounted with VectaMount.
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Page 16 of 18In the data analysis, mRNA expression was quantified
by a Nikon Eclipse E800 microscope as a brown reaction.
Fifteen random fields were counted at 400× magnifica-
tion for each preparation, according to a modification of
the point-counting stereological method [91] using an
intraocular reticle of 27-mm diameter, covering 3578 μm2
(Kr409, Klarman Rulings) [83]. Volumetric density (Vvi)
analysis of the different probes was performed to mea-
sure the number of intersections of the grid that fell on
the positive brown reaction. Statistical significance was
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